The Effect of Motivational Interviewing on Self-Efficacy and Quality of Life in Gestational Diabetes Mellitus
Launched by CUKUROVA UNIVERSITY · Feb 5, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a technique called motivational interviewing can help pregnant women with gestational diabetes manage their health better and improve their quality of life. Motivational interviewing is a supportive way of talking that helps people feel more confident and motivated to make healthy choices. The study is specifically focusing on women who are pregnant for the first time and are between 24-28 weeks along in their pregnancy. To participate, women need to be able to speak and understand Turkish, have a single healthy baby, and regularly attend check-ups at the same hospital.
If eligible, participants will engage in sessions where they will receive guidance and support to help them manage their diabetes during pregnancy. This trial aims to see if this kind of support can lead to better self-efficacy, meaning feeling more capable of handling health-related challenges, and overall better quality of life. It’s important to note that women with certain medical conditions or who do not wish to continue the study will not be included. Overall, this research could provide valuable insights for improving care for expectant mothers dealing with gestational diabetes.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being pregnant for the first time
- • Being diagnosed with gestational diabetes mellitus
- • 24-28. Being in the pregnancy week
- • Being able to speak and understand Turkish
- • Being 18 years or older
- • Having a single and viable fetus
- • Volunteering to participate in research
- • Having and being able to use a mobile phone
- • Having all check-ups at the same hospital and regularly throughout pregnancy,
- Exclusion Criteria:
- • Being diagnosed with diabetes mellitus (type 1, type 2 diabetes) before pregnancy
- • Having a psychiatric diagnosis,
- • Having a chronic disease
- • Having risk factors such as threat of premature birth, placenta previa, premature rupture of membranes
- • Having any disability that would prevent communication (deafness, hearing impairment, etc., use of languages other than Turkish),
- • Pregnant women who do not want to continue the study and give birth before the 37th week of pregnancy will be excluded from the study.
About Cukurova University
Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adana, Sarıçam, Turkey
Adana, , Turkey
Patients applied
Trial Officials
Meltem Akbaş, PhD
Principal Investigator
Universty Of Cukurova
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported